Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1975]
News [3813]
Articles [100]
Editorials [5]
Conferences [165]
elearning [19]
Nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple...
Dr Iris Nederlof - The Netherlands Cancer Institute, Amsterdam, Netherlands
Nivolumab and ipilimumab with tumour-infiltrating lymphocytes to treat triple-negative breast cancer ( Dr Iris Nederlof - The Netherlands Cancer Institute, Amsterdam, Netherlands )
12 Sep 2022
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in...
Prof Siow-Ming Lee - University College London, London, UK
Results from a phase 3 study of 1L atezolizumab vs single-agent chemotherapy in pts with NSCLC ( Prof Siow-Ming Lee - University College London, London, UK )
12 Sep 2022
RADICALS-HD trial: androgen deprivation therapy with post-operative...
Prof Chris Parker - Institute of Cancer Research, Sutton, UK
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prostate cancer ( Prof Chris Parker - Institute of Cancer Research, Sutton, UK )
12 Sep 2022
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine...
Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht...
Extended adjuvant AI not advised for HPBC after 5+ yrs of sequential endocrine therapy ( Dr Vivianne Tjan-Heijnen - Maastricht University Medical Center, Maastricht, Netherlands )
11 Sep 2022
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer
Prof Jean Emmanuel Kurtz - Strasbourg Cancer Institute, Strasbourg, France
Atezolizumab added to chemo fails to improve PFS in relapsed ovarian cancer ( Prof Jean Emmanuel Kurtz - Strasbourg Cancer Institute, Strasbourg, France )
10 Sep 2022
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly...
Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands
Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma ( Dr John B Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )
10 Sep 2022
WCLC 2022: Highlights
Dr Luis Raez - Memorial Cancer Institute, Florida, USA
WCLC 2022: Highlights ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
31 Aug 2022
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for August 15th - 21st, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
22 Aug 2022
An overview of treatment advances in gastric cancer
Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA
An overview of treatment advances in gastric cancer ( Prof David Ilson - Memorial Sloan Kettering Cancer Center, New York City, USA )
18 Aug 2022
Working to improve global cancer care access in low middle-income countries
Dr Julie Gralow, Prof Eduardo Cazap
Working to improve global cancer care access in low middle-income countries ( Dr Julie Gralow, Prof Eduardo Cazap )
25 Jul 2022
Impact of BRAF-V600E mutation on the tumour microenvironment and associated...
Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )
20 Jul 2022
ASCO Direct Highlights 2022: lung cancer highlights
Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
ASCO Direct Highlights 2022: lung cancer highlights ( Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA )
9 Jul 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation